Abstract
The vagus nerve, also known as the 10th cranial nerve, is a critical component of the parasympathetic nervous system, playing a fundamental role in the regulation of various physiological functions, including glucose metabolism and cardiac regulation. Originating in the brainstem, the vagus nerve extends through the neck and thorax to the abdomen, innervating major organs such as the heart, lungs, and digestive tract. Central to its function is the dorsal motor nucleus of the vagus (DMV), located in the medulla oblongata, which serves as a primary source of vagal efferent fibers.
The vagus nerve significantly influences glucose homeostasis. It modulates pancreatic insulin secretion and hepatic glucose production through its efferent and afferent pathways. The efferent fibers of the vagus nerve facilitate the release of insulin from the pancreas, thus promoting glucose uptake by tissues and maintaining blood glucose levels. Additionally, the DMV has been implicated in the feed forward release of insulin prior to meal consumptions known as the cephalic phase insulin response. Dysregulation of vagal activity has been implicated in metabolic disorders such as diabetes mellitus, where impaired vagal signaling can lead to reduced insulin sensitivity and abnormal glucose production.
In addition to its role in metabolic control, the vagus nerve exerts a profound influence on cardiac function. It modulates heart rate, myocardial contractility, and atrioventricular conduction through its extensive innervation of the heart. The vagal efferent fibers, originating from the DMV, release acetylcholine, which binds to muscarinic receptors on cardiac cells, leading to a decrease in heart rate (negative chronotropic effect) and a reduction in the force of contraction (negative inotropic effect). This parasympathetic control counterbalances the sympathetic nervous system, maintaining cardiovascular stability. Furthermore, the effects of the DMV and vagus nerve on the heart are clinically significant for mood disorders such as anxiety and post-traumatic stress disorder (PTSD), where dysregulated heart rate variability and vagal tone have been observed. Dysfunction in vagal activity has been associated with various cardiac pathologies, including arrhythmias and heart failure, where diminished vagal tone can exacerbate disease progression.
This dissertation aims to explore the intricate roles of the vagus nerve and the DMV in regulating glucose tolerance and cardiac functions. By elucidating the mechanisms underlying vagal control of these vital processes, this research seeks to contribute to a better understanding of how autonomic dysregulation can lead to metabolic and cardiovascular phenotypes and how these systems may be therapeutically targeted for interventions.
Understanding the multifaceted roles of the vagus nerve and the DMV in glucose and cardiac regulation is crucial for developing novel strategies to treat metabolic and cardiovascular disorders. This dissertation will delve into the physiological, cellular, and molecular mechanisms by which the vagus nerve maintains homeostasis, highlighting its importance as a therapeutic target in modern medicine.
